WHO ICTRP trial
Vortioxetine to Prevent Return of Symptoms in Children With Depression
EUCTR2010-020493-42-BG · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2010-020493-42-BG |
|---|---|
| Public title | Vortioxetine to Prevent Return of Symptoms in Children With Depression |
| Scientific title | A Double-blind, Randomized, Placebo-controlled, Multicentre, Relapse-prevention Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder |
| Primary sponsor | H. Lundbeck A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | United States;Serbia;Mexico;Argentina;Spain;Poland;Ukraine;Russian Federation;Bulgaria;Latvia;Colombia |
| Conditions | Major Depressive Disoder;Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03] |
| Interventions | Trade Name: Brintellix 20 mg encapsulated film-coated tablets Product Name: Vortioxetine Pharmaceutical Form: Film-coated tablet INN or Proposed INN: VORTIOXETINE CAS Number: 508233-74-7 Concentration unit: mg milligram(s) Concentration… |
| Registration date | Mar 25, 2021 |
| Target size | 150 |
| Secondary IDs | 13546A |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: